Metropolitan Life Insurance Company (MetLife)’s Stemline Therapeutics, Inc. STML Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q2 | – | Sell |
|
|||||
2020
Q1 | $66.4K | Buy |
|
|||||
2019
Q4 | $127K | Sell |
|
|||||
2019
Q3 | $139K | Hold |
|
|||||
2019
Q2 | $205K | Hold |
|
|||||
2019
Q1 | $172K | Buy |
|
|||||
2018
Q4 | $81K | Hold |
|
|||||
2018
Q3 | $141K | Hold |
|
|||||
2018
Q2 | $137K | Buy |
|
|||||
2018
Q1 | $124K | Hold |
|
|||||
2017
Q4 | $126K | Sell |
|
|||||
2017
Q3 | $175K | Buy |
|
|||||
2015
Q2 | – | Sell |
|
|||||
2015
Q1 | $185K | Buy |
|
|||||
2014
Q2 | – | Sell |
|
|||||
2014
Q1 | $162K | Hold |
|
|||||
2013
Q4 | $156K | Hold |
|
|||||
2013
Q3 | $361K | Hold |
|
|||||
2013
Q2 | $190K | Buy |
|